These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10240328)

  • 21. Windfall warning.
    Nature; 2009 Oct; 461(7266):847-8. PubMed ID: 19829323
    [No Abstract]   [Full Text] [Related]  

  • 22. Increased NIH funding needed to combat cancer in minorities, medically underserved.
    Oncology (Williston Park); 1999 May; 13(5):617. PubMed ID: 10356682
    [No Abstract]   [Full Text] [Related]  

  • 23. John Niederhuber: thinking like a director.
    Vanchieri C
    J Natl Cancer Inst; 2006 Sep; 98(18):1266-8. PubMed ID: 16985241
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinton's technology agenda.
    Hamilton DP
    Science; 1992 Nov; 258(5085):1076-8. PubMed ID: 1439813
    [No Abstract]   [Full Text] [Related]  

  • 25. Stat bite: NCI R01 success rates, 1970-2005.
    J Natl Cancer Inst; 2006 Oct; 98(20):1437. PubMed ID: 17047188
    [No Abstract]   [Full Text] [Related]  

  • 26. Is drug development too slow? NIH to the rescue!
    Weissmann G
    FASEB J; 2011 Apr; 25(4):1119-22. PubMed ID: 21454369
    [No Abstract]   [Full Text] [Related]  

  • 27. Stat bite: NIH, NCI appropriations, 1997-2007.
    J Natl Cancer Inst; 2006 Mar; 98(6):376. PubMed ID: 16537826
    [No Abstract]   [Full Text] [Related]  

  • 28. US cancer research strategy revised.
    Novak K
    Nat Med; 2001 Dec; 7(12):1266. PubMed ID: 11726952
    [No Abstract]   [Full Text] [Related]  

  • 29. Thinking outside the box: NINDS and the clinical research collaboration.
    Anderson DC
    Neurology; 2008 May; 70(19):1656-7. PubMed ID: 18458225
    [No Abstract]   [Full Text] [Related]  

  • 30. Klausner follows own advice at NCI.
    Marshall E
    Science; 1995 Aug; 269(5226):912-3. PubMed ID: 7638609
    [No Abstract]   [Full Text] [Related]  

  • 31. NCI seeks partnership with HMOs.
    Kertesz L
    Mod Healthc; 1996 Jun; 26(26):12. PubMed ID: 10158321
    [No Abstract]   [Full Text] [Related]  

  • 32. Diabetes research getting shortchanged?
    Ho S
    Nephrol News Issues; 2006 Jul; 20(8):31. PubMed ID: 16859231
    [No Abstract]   [Full Text] [Related]  

  • 33. The state of support for research on the epidemiology, prevention, and treatment of drug use and drug use disorders in the USA.
    Sloboda Z
    Subst Use Misuse; 2012; 47(13-14):1557-68. PubMed ID: 23186473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new era for cancer prevention and control research.
    Engstrom PF
    Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):955-6. PubMed ID: 10566548
    [No Abstract]   [Full Text] [Related]  

  • 35. Complementary/alternative medicine and cancer research. A national initiative.
    Richardson MA; White JD
    Cancer Pract; 2000; 8(1):45-8. PubMed ID: 10732539
    [No Abstract]   [Full Text] [Related]  

  • 36. What's going on with research project grant funding at NCI?
    Kerkvliet GJ
    J Natl Cancer Inst; 1990 May; 82(10):810-2. PubMed ID: 2332894
    [No Abstract]   [Full Text] [Related]  

  • 37. NCI: a lab scientist's view, from the director's office.
    Klausner R
    Science; 1996 Sep; 273(5280):1329-30. PubMed ID: 8801626
    [No Abstract]   [Full Text] [Related]  

  • 38. Research report from the NIH: introduction to the NIH and the NCI director's year 2015 challenge goal.
    Wallner PE
    J Am Coll Radiol; 2004 Jan; 1(1):16-7. PubMed ID: 17411513
    [No Abstract]   [Full Text] [Related]  

  • 39. Science and the war on drugs: a hard habit to break.
    Pearson H
    Nature; 2004 Jul; 430(6998):394-5. PubMed ID: 15269737
    [No Abstract]   [Full Text] [Related]  

  • 40. Researchers isolate ominous trend in grants.
    Tokarski C
    Mod Healthc; 1989 Dec; 19(50):18. PubMed ID: 10296458
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.